Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease

SGLT2 inhibitors are new antihyperglycaemic agents whose ability to lower glucose is directly proportional to GFR. Therefore, in chronic kidney disease (CKD) the blood glucose lowering effect is reduced. Unlike many current therapies, the mechanism of action of SGLT2 inhibitors is independent of ins...

Full description

Saved in:
Bibliographic Details
Published in:ScientificWorldJournal
Main Authors: Zanoli, L., Granata, A., Lentini, P., Rastelli, S., Fatuzzo, P., Rapisarda, F., Castellino, P.
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2015
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4345065/
https://ncbi.nlm.nih.gov/pubmed/25785281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317507
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items